Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Ruth Porther* , Kate Thorburn, Lauren Evans, Priya Fernando
Background Hospital at home (HaH) teams are in a position to offer escalation of treatment in the communityfor frail older patients with COVID-19 infection to avoid potential adverse outcomes of hospitalisation. Torfaen Community Resource Team (CRT) is one such HaH team in South Wales. Objective To evaluate the outcomes ofpatients with COVID-19 infection managed by Torfaen CRT. Methods Prospective records were kept of all patients under the care of Torfaen CRT who received a nasopharyngeal PCR test for possible COVID-19 infection betweenMarch 2020 and March 2021. An audit was undertaken collecting data on test results, severity of COVID-19 infection, treatment given, elements of advanced care planning and outcome on discharge. Results 32 patients weremanaged under Torfaen CRT as positive for or likely COVID-19 infection. 24 patients (75%) were managed withmoderate to severe COVID-19 infection. 16 (50%) patients were discharged having been successfully managed in the community, 13 (41%) were admitted and 3 (9%) died having been managed as being in the last stages of life. Fourweeks after discharge from our care, only 2 patients were admitted to hospital or re-referred to Torfaen CRT and no patients were diagnosed with VTE. Conclusions and Implications Half of patients with COVID-19 infection were successfully managed at home under Torfaen CRT. Here we discuss the framework used by our team to structure a multidisciplinary approach to manage these patients in the community and the need for robust evidence to guide management of patients with COVID-19 infection in this setting. Avenues for further research may includevalidating a HaH admission score for patients with COVID-19 infection and determining the evidence base for recommendations such as VTE prophylaxis and treatment with systemic corticosteroids in the communit